626 Financial, LLC Pfizer Inc Transaction History

626 Financial, LLC

$177 Million
Q3 2024

A detailed history of 626 Financial, LLC transactions in Pfizer Inc stock. As of the latest transaction made, 626 Financial, LLC holds 42,335 shares of PFE stock, worth $1.12 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

42,335

Previous 41,405 2.25%

Holding current value

$1.12 Million

Previous $1.16 Million 5.79%

% of portfolio

0.69%

Previous 0.68%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $25,761 - $29,192	930 Added 2.25%	42,335 $1.23 Million
Q2 2024 Jul 12, 2024	BUY	$25.26 - $29.6 $38,976 - $45,672	1,543 Added 3.87%	41,405 $1.16 Million
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $66,847 - $76,762	2,582 Added 6.93%	39,862 $1.11 Million
Q4 2023 Jan 11, 2024	SELL	$26.13 - $33.94 $108,962 - $141,529	-4,170 Reduced 10.06%	37,280 $1.07 Million
Q3 2023 Oct 11, 2023	BUY	$32.09 - $37.51 $111,191 - $129,972	3,465 Added 9.12%	41,450 $1.37 Million
Q2 2023 Jul 14, 2023	BUY	$36.12 - $41.79 $7,910 - $9,152	219 Added 0.58%	37,985 $1.39 Million
Q1 2023 Apr 12, 2023	BUY	$39.39 - $51.28 $37,617 - $48,972	955 Added 2.59%	37,766 $1.54 Million
Q4 2022 Jan 24, 2023	BUY	$41.75 - $54.5 $303,439 - $396,106	7,268 Added 24.6%	36,811 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $291,397 - $355,723	6,659 Added 29.1%	29,543 $1.29 Million
Q2 2022 Jul 12, 2022	BUY	$46.53 - $55.17 $39,178 - $46,453	842 Added 3.82%	22,884 $1.2 Million
Q1 2022 May 05, 2022	BUY	$45.75 - $56.69 $53,847 - $66,724	1,177 Added 5.64%	22,042 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $48,633 - $72,091	-1,177 Reduced 5.34%	20,865 $1.23 Million
Q1 2021 Apr 14, 2022	BUY	$33.49 - $37.77 $738,186 - $832,526	22,042 New	22,042 $1.14 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 626 Financial, LLC with notifications on news.

Account

626 Financial, LLC Pfizer Inc Transaction History